Probiodrug and Its Collaborators Will Present Novel Insights into the Pathophysiology of Alzheimer’s Disease at Society for Neuroscience’s Neuroscience 2011 Conference in Washington, D.C.

Neurodegeneration in Alzheimer’s Disease: The crucial role of QC
Probiodrug Announces Top-Line Results of the First Clinical Study of PQ912 for Treatment of Alzheimer’s Disease